Chapter 71 Hematologic Manifestations of HIV/AIDS
Peripheral Blood Smear and Bone Marrow Morphology in HIV/AIDS
AIDS, Acquired immunodeficiency syndrome; HIV, human immunodeficiency virus.
Stage | Laboratory Evidence | Clinical Evidence |
---|---|---|
Stage1 | Laboratory confirmation of HIV infection and CD4+ T-lymphocyte count of ≥500 cells/µL or CD4+ T-lymphocyte percentage of ≥29* | No AIDS-defining condition (see Table 71-2) |
Stage 2 | Laboratory confirmation of HIV infection and CD4+ T-lymphocyte count of 200-499 cells/µL or CD4+ T-lymphocyte percentage of 14-28* | No AIDS-defining condition (see Table 71-2) |
Stage 3 | Laboratory confirmation of HIV infection and CD4+ T-lymphocyte count of <200 cells/µL or CD4+ T-lymphocyte percentage of <14* | Documentation of an AIDS-defining condition with laboratory confirmation of HIV infection (see Table 71-2) |
Stage unknown | Laboratory confirmation of HIV infection and no information on CD4+ T-lymphocyte count or percentage | No information on presence of an AIDS-defining condition |
AIDS, Acquired immunodeficiency syndrome; HIV, human immunodeficiency virus.
*The CD4+ T-lymphocyte percentage is the percentage of the total lymphocyte count.
Pneumocystis jiroveci (carinii) Candidiasis: esophageal and systemic Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here
|